当前位置: 首页 > 期刊 > 《中华实用医药杂志》 > 2004年第16期
编号:10575427
甲地孕酮在肝癌介入化疗中的应用观察
http://www.100md.com 《中华实用医药杂志》 2004年第16期
生活质量,肝癌,介入化疗,甲地孕酮,生活质量,1对象与方法,2结果,3讨论,参考文献
     【摘要】 目的 观察甲地孕酮对肝癌介入化疗病人毒性的减低和生活质量改善情况。方法 治疗组采用介入化疗配合甲地孕酮;对照组只采用介入化疗。结果 治疗组恶心、呕吐、反应明显少于对照组;治疗组体重增加优于对照组。结论 甲地孕酮可明显减轻肝癌介入化疗病人的化疗副作用;亦可明显改善此类病人的生活质量。从而有利于完成系统介入治疗,提高疗效。

    关键词 肝癌 介入化疗 甲地孕酮 生活质量

    The clinical study from megace in interventional chemical therapy of liver cancer

    Li Dawei,Yuan Long,Li Wei

    Department of Interventional Therapy,Heilongjiang Province Hospital,Harbin150036.

    【Abstract】 Objective To explore the probality and outcomes of Megace and to improve the quality of life with liver cancer.Methods The tested group uses Megace and interventional chemical therapy;the controlled group only uses interventional therapy.Results The side effect of the tested group is more less than the controlled group.Conclusion Megace can obviously reduce side effects of interventional chemical therapy and improve their quality of life.This can have a help to cure patients systematically and to increase good effects.

    Key words liver cancer interventional chemical therapy megace life quality

    肝癌是严重的恶性肿瘤 ......

您现在查看是摘要页,全文长 4253 字符